Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Immunomodulatory activity of interferon-beta.
Effect of Boswellia papyrifera on cognitive impairment in multiple sclerosis.
Flavonoid-Based Therapies in the Early Management of Neurodegenerative Diseases.
The high cost of spasticity in multiple sclerosis to individuals and society.
The Future of Research in Multiple Sclerosis.
Treatment of Chronic Experimental Autoimmune Encephalomyelitis with Epigallocatechin-3-Gallate and Glatiramer Acetate Alters Expression of Heme-Oxygenase-1.
Immunosuppressive treatments in multiple sclerosis.
Failed, interrupted and inconclusive trials on relapsing multiple sclerosis treatment: update 2010-2015.
Resveratrol augments therapeutic efficiency of mouse bone marrow mesenchymal stem cell-based therapy in experimental autoimmune encephalomyelitis.
Multiple Sclerosis Therapy With Disease-Modifying Treatments in Germany: The PEARL (ProspEctive phArmacoeconomic cohoRt evaluation) Noninterventional Study Protocol.
Comparison of Two Molecular Scaffolds, 5-Methylisoxazole-3-Carboxamide and 5-Methylisoxazole-4-Carboxamide.
Persistent Inflammation in the CNS during Chronic EAE Despite Local Absence of IL-17 Production.
[Non-medicinal treatments of spasticity in multiple sclerosis].
Predictors of driving in individuals with relapsing-remitting multiple sclerosis.
Peripheral inflammatory disease associated with centrally activated IL-1 system in humans and mice.
Sphingosine-1-phosphate receptors as emerging targets for treatment of pain.
Apitope starts new clinical trial of its investigational Multiple Sclerosis treatment
Cognitive correlates of under-ambiguity and under-risk decision making in high-functioning patients with relapsing remitting multiple sclerosis.
Italian validation of the 12-item multiple sclerosis walking scale.
Delayed initial recovery and long lie following a fall among middle-aged and older adults with multiple sclerosis.
Event related potential and response time give evidence for a physiological reserve in cognitive functioning in relapsing-remitting multiple sclerosis.
Retinal nerve fiber layer thickness in benign multiple sclerosis.
Multiple sclerosis: Atacicept increases relapse rates in multiple sclerosis.
Diet, microbiota and autoimmune diseases.
Transplantation of Fas-deficient or wild-type neural stem/progenitor cells (NPCs) is equally efficient in treating experimental autoimmune encephalomyelitis (EAE).

Pages